MedPath

Diagnostic Performance of Exercise Stress Tests for the Detection of Epicardial and Microvascular Coronary Artery Disease

Completed
Conditions
Coronary Artery Disease
Registration Number
NCT05231161
Lead Sponsor
Onze Lieve Vrouw Hospital
Brief Summary

Prospective, single-arm, multicenter study of patients with an intermediate pre-test probability of CAD and positive exercise stress tests referred for invasive angiography. Patients underwent an invasive diagnostic procedure (IDP) with measurement of fractional flow reserve (FFR) and index of microvascular resistance (IMR) in at least one coronary vessel. The objective was to determine the false discovery rate (FDR) of cardiac exercise stress tests with both FFR and IMR as references.

Detailed Description

The Redefining the Diagnostic Performance of Non-invasive Tests for the Detection of Coronary Artery Disease: UZ Clear is an investigator-initiated, single-arm, multicenter, prospective study of patients presenting with chest pain with an intermediate probability of CAD. The intermediate pre-test probability of CAD was defined based on the European Society of Cardiology Guidelines as a score between 15% and 85% based on age, sex, and the nature of symptoms. All patients had a positive exercise stress test and were referred for an invasive evaluation. Patients underwent a study protocol with an invasive diagnostic procedure (IDP) consisting of measurements of FFR and IMR in at least one coronary vessel. Exclusion criteria are acute coronary syndromes, known coronary artery disease, previous myocardial infarction, previous revascularization, and abnormal baseline electrocardiogram (ECG). All data were centrally collected and analyzed by the core laboratory.

The primary objective was to determine the false discovery rate of exercise stress tests using an interventional diagnostic procedure (IDP) with indexes of epicardial (FFR) and microvascular resistance (IMR) as clinical references. The secondary objective was to assess the impact of an IDP accounting for the presence of CMD on the accuracy of exercise stress tests.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
114
Inclusion Criteria
    1. Stable angina-like chest pain (typical or atypical) with intermediate (15-85%) pre-test probability of coronary artery disease using the ESC criteria.
  1. Positive non-invasive exercise test, or inconclusive stress with additional positive imaging.
Exclusion Criteria
  1. Age <30 or >80-year old
  2. Acute coronary syndromes.
  3. Known coronary artery disease
  4. Inability to perform exercise tests.
  5. Previous myocardial infarction.
  6. Previous CABG/PCI
  7. Left ventricular dysfunction EF <35% or NYHA class III-IV
  8. Uncontrolled or recurrent ventricular tachycardia
  9. Atrial fibrillation
  10. Severe renal dysfunction, defined as an eGFR <30 ml/min/1.73m2
  11. Contra-indication to adenosine (e.g. asthma bronchial, severe COPD)
  12. Active cancer
  13. Recent stroke
  14. Cardiomyopathy (dilated, hypertrophic, amyloidosis, arrhythmogenic right ventricular dysplasia)
  15. Left Bundle Branch Block or baseline ST-segment depression >1mm.
  16. Congenital heart disease
  17. More than moderate valve disease

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The primary objective was to determine the false discovery rate of exercise stress tests using an interventional diagnostic procedure (IDP) with indexes of epicardial (FFR) and microvascular resistance (IMR) as clinical references.Immediately post-procedural

Diagnostic performance of exercise tests with false discovery rate

Secondary Outcome Measures
NameTimeMethod
to assess the impact of an IDP accounting for the presence of CMD on the accuracy of exercise stress tests.Immediately post-procedural

Comparison of false discovery rates using QCA, FFR and IMR as gold standards

Trial Locations

Locations (1)

OLV Aalst

🇧🇪

Aalst, Oost Vlanderen, Belgium

© Copyright 2025. All Rights Reserved by MedPath